These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1101 related items for PubMed ID: 19252949

  • 1. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK, Sutton C, Rotimi O, Dexter S, Sue-Ling H, Sarela AI.
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [Abstract] [Full Text] [Related]

  • 2. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N.
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
    Peracchia A, Bonavina L, Via A, Incarbone R.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM, Ayazi S, Hagen JA, Terterov S, Klipfel N, Oezcelik A, Abate E, Lipham JC, DeMeester SR, Banki F, DeMeester TR.
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [Abstract] [Full Text] [Related]

  • 10. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ, Liu Q, Liang RX, Qu FS, Yan TX, Sun YH, Li XQ.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [Abstract] [Full Text] [Related]

  • 11. How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus.
    Verhage RJ, Zandvoort HJ, ten Kate FJ, van Hillegersberg R.
    Am J Surg Pathol; 2011 Jun; 35(6):919-26. PubMed ID: 21566512
    [Abstract] [Full Text] [Related]

  • 12. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF.
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [Abstract] [Full Text] [Related]

  • 13. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gonen M, Kelsen DP, Brennan MF, Coit DG.
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C, Taillier G, Van Seuningen I, Triboulet JP.
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [Abstract] [Full Text] [Related]

  • 15. The prognostic value of circumferential resection margin involvement in oesophageal malignancy.
    Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM.
    Eur J Surg Oncol; 2006 May; 32(4):413-9. PubMed ID: 16504455
    [Abstract] [Full Text] [Related]

  • 16. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C, Piessen G, Briez N, Triboulet JP.
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [Abstract] [Full Text] [Related]

  • 19. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [Abstract] [Full Text] [Related]

  • 20. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M.
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.